Neurological updates: neurological complications of CAR-T therapy

Chimeric antigen receptor (CAR)-expressing T cells now offer an effective treatment option for people with previously refractory B cell malignancies and are under development for a wide range of other tumours. However, neurological toxicity is a common complication of CAR-T cell therapy, seen in ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Tallantyre, Emma C., Evans, Nia A., Parry-Jones, Jack, Morgan, Matt P. G., Jones, Ceri H., Ingram, Wendy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Neurological Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990806/
https://www.ncbi.nlm.nih.gov/pubmed/33140239
http://dx.doi.org/10.1007/s00415-020-10237-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990806/
https://www.ncbi.nlm.nih.gov/pubmed/33140239
http://dx.doi.org/10.1007/s00415-020-10237-3

Ejemplares similares